RyCarma Therapeutics announced that the first patient has been dosed in its Phase 2 clinical trial of surlorian (ARM210), an investigational treatment for RYR1-Related Myopathy (RYR1-RM)!
🔗 Learn more: biospace.com/press-releases/…
#strengthinnumbersryr1 #ryr1rd #ryr1 #ryr1community
25
💙 15 DAYS UNTIL GIVINGTUESDAY! 💙
The countdown is on! In just 15 days, our RYR-1-RD community will come together for GivingTuesday on December 1.
Help secure the $45,000 match!
24
💙 GivingTuesday is getting closer! On 12/1, we can come together and make a difference for individuals and families living with RYR-1-RD. Your support helps us continue investing in research, patient and family support, education, and advocacy. Help activate the $45,000 match!
📢 TODAY'S THE DAY!
Join us TODAY, November 11, at 11:00 AM ET for our webinar, “Periodic Paralysis & RYR1 Mutations: Understanding the Connection!”
🔗 Register here: us02web.zoom.us/webinar/regi…
#strengthinnumbersryr1 #ryr1rd #ryr1 #ryr1community
1
2
52
📢 Upcoming Webinar: Periodic Paralysis & RYR1 Mutations!
Join The RYR-1 Foundation and the Periodic Paralysis Association tomorrow, November 11 at 11:00 AM ET to explore this emerging area of research.
🔗us02web.zoom.us/webinar/regi…
#strengthinnumbersryr1 #ryr1rd #ryr1 #ryr1community
🎉 A Milestone Worth Celebrating!
The manuscript from The RYR-1 Foundation’s 2025 Patient-Led International Research Workshop has been published in the Journal of Neuromuscular Diseases!
📖 Read the publication: journals.sagepub.com/doi/10.…
2
27
Join advocates from across the country March 2 - 4 in Washington, DC, to share your story and make your voice heard on Capitol Hill! The RARE Foundation is offering travel reimbursements for individuals/caregivers attending.
Application Deadline: 11/6/26
bit.ly/4fbVlaz
📰 Our November Newsletter Is Here!
As we approach GivingTuesday & the end of the year, we're excited to share that our Board of Directors has pledged $45,000 to MATCH year-end donations!
ryr1.org/newsletters/novembe…
2
31
✨ Save the Date: GivingTuesday 2026!
The countdown has begun! On 12/1, we’ll come together for GivingTuesday, a global day dedicated to generosity and supporting the causes that matter most. 💙
Together, we can make a difference. Strength In Numbers.
📅 GivingTuesday: 12/1/26
A new pilot project to develop a research test to clarify VUS in the RYR1 gene.
Eligibility:
Confirmed diagnosis due to recessive RYR1 variants
Symptom onset at birth or during childhood
Email: [email protected]
The NIH is enrolling participants in a Natural History Study of RYR-1-Related Disorders (RYR-1-RD) to better understand how these conditions affect individuals over time.
📞 (800) 411-1222
📧 [email protected]
🔎 Reference Study #001737-CC
ryr1.org/wp-content/uploads/…
1
30
Clinical Trial Opportunity for RYR1-Related Myopathy
A Phase 2 clinical trial is evaluating Surlorian (ARM210, S48168), an investigational therapy for adults with autosomal dominant RYR1-Related Myopathy (RYR1-RM).
👉 Learn more about the study clinicaltrials.gov/study/NCT…
Missed Our September Webinar?
No worries! The recording of “RYR1 Mutations and Statins: What Clinicians and Patients Should Know” is now available on our website!
Thank you to Dr. Marks & Dr. Van Petegem for sharing their expertise!
Watch here 👉 vimeo.com/1227100479?fl=pl&f…
Join us and the Periodic Paralysis Association on November 11 at 11:00 AM ET for:
“Periodic Paralysis & RYR1 Mutations: Understanding the Connection”
💻 Don’t miss this informative discussion!
Register here: us02web.zoom.us/webinar/regi…
38
A new study published in Neuromuscular Disorders examined how RYR1-Related Malignant Hyperthermia (MH) susceptibility and Exertional Rhabdomyolysis (ERM) affect daily life.
Read Full Article 👉nmd-journal.com/article/S096…
A new study published in eClinicalMedicine found that salbutamol may improve motor function in children and teens with congenital myopathies, including participants with RYR-1-RD.
Read Article👉 thelancet.com/journals/eclin…
📰 Our October Newsletter Is Here! 💙
Stay up to date with the latest from The RYR-1 Foundation! Our October Newsletter is now available and includes exciting news!
📖 Read the October Newsletter: ryr1.org/newsletters/october…
26
Did you miss our September Webinar?
No worries! The recording is now available on our website. 🎥
Learn more about “RYR1 Mutations and Statins: What Clinicians and Patients Should Know”
Watch the webinar today! vimeo.com/1227100479?share=c…
1
73
The NIH Natural History Study of RYR1-Related Disorders is still enrolling participants! This study helps researchers better understand how RYR-1-RD affects individuals over time and can help improve care and support the development of future treatments.
bit.ly/4fAMX5r
1
39
🧬 Hope Through Research: Advancing Potential RYR1 Treatments. A renewed NIH grant led by Dr. Dirksen & Dr. Dowling is advancing innovative approaches to RYR1-related myopathy, including research by Dr. Tasfaout!
👉bit.ly/4i80zqg
1
54
